GSK outlines $30 billion US push in R&D and manufacturing
GSK’s $30 billion investment plan marks a major step in reshaping how the biopharma industry connects...
Read more
Pharma
AstraZeneca commits $4.5B to build US drug hub in Virginia
AstraZeneca is putting $4.5 billion behind a future-focused strategy in Albemarle County, Virginia.
Read more
GSK joins industry push with $30B plan for US drug production
GSK has announced a $30 billion commitment to expand R&D and manufacturing capacity in the US...
Read more
Eli Lilly invests $5B in Virginia in a new US hub for drug manufacturing
Eli Lilly's newest facility in Concord, Virginia, could redefine how pharmaceutical companies think about scale, security,...
Read more
Gilead launches next-generation manufacturing hub amid $32B spend
Gilead Sciences has started construction on a five-story, 180,000-square-foot manufacturing hub in Foster City, California.
Read more